Works matching IS 27709183 AND DT 2023 AND VI 2 AND IP 3

Results: 10

PD‐1/L1 inhibitors can improve but not replace chemotherapy for advanced urothelial carcinoma: A systematic review and network meta‐analysis.
Published in:
Cancer Innovation, 2023, v. 2, n. 3, p. 191, doi. 10.1002/cai2.75
By:
- Mao, Longkun;
- Yang, Meihua;
- Fan, Xinxiang;
- Li, Wenjie;
- Huang, Xiaodong;
- He, Wang;
- Lin, Tianxin;
- Huang, Jian
Publication type:
Article
Particle implantation combined with chemotherapy for rhabdomyosarcoma of the head and neck: A 8‐year long‐term follow‐up case report.
Published in:
Cancer Innovation, 2023, v. 2, n. 3, p. 233, doi. 10.1002/cai2.71
By:
- He, Sidou;
- Tian, Shuhang;
- Xu, Na;
- Zhang, Jianguo;
- Duan, Chao;
- Ma, Xiaoli
Publication type:
Article
A real‐world study of immune checkpoint inhibitors in advanced triple‐negative breast cancer.
Published in:
Cancer Innovation, 2023, v. 2, n. 3, p. 172, doi. 10.1002/cai2.70
By:
- Zhang, Zheng;
- Zhang, Yadi;
- Liu, Chuanling;
- Shao, Jiakang;
- Chen, Yimeng;
- Zhu, Yimin;
- Zhang, Li;
- Qin, Boyu;
- Kong, Ziqing;
- Wang, Xixi;
- Wang, Yutong;
- Huang, Deqin;
- Liu, Liqun;
- Zhou, Yuxin;
- Tao, Ran;
- Yang, Zengjie;
- Liu, Mei;
- Zhao, Weihong
Publication type:
Article
A bibliometric analysis of worldwide cancer research using machine learning methods.
Published in:
Cancer Innovation, 2023, v. 2, n. 3, p. 219, doi. 10.1002/cai2.68
By:
- Lin, Lianghong;
- Liang, Likeng;
- Wang, Maojie;
- Huang, Runyue;
- Gong, Mengchun;
- Song, Guangjun;
- Hao, Tianyong
Publication type:
Article
Chaotic fractals: Why chaos is the dynamic of carcinogenesis.
Published in:
Cancer Innovation, 2023, v. 2, n. 3, p. 165, doi. 10.1002/cai2.63
By:
- Tez, Mesut
Publication type:
Article
Flexible bioelectronic innovation for personalized health management.
Published in:
Cancer Innovation, 2023, v. 2, n. 3, p. 167, doi. 10.1002/cai2.61
By:
- Xie, Maowen;
- Yao, Guang;
- Lin, Yuan
Publication type:
Article
Symphony in the crowd: Key genetic alterations in prostate cancer.
Published in:
Cancer Innovation, 2023, v. 2, n. 3, p. 203, doi. 10.1002/cai2.52
By:
- Masud, Neshat
Publication type:
Article
Role of YES1 signaling in tumor therapy resistance.
Published in:
Cancer Innovation, 2023, v. 2, n. 3, p. 210, doi. 10.1002/cai2.51
By:
- Zhou, Hai;
- Sun, Dantong;
- Tao, Junyan;
- Xu, Mingjin;
- Zhang, Xiaochun;
- Hou, Helei
Publication type:
Article
Third‐line or above anlotinib in relapsed and refractory small cell lung cancer patients with brain metastases: A post hoc analysis of ALTER1202, a randomized, double‐blind phase 2 study.
Published in:
Cancer Innovation, 2023, v. 2, n. 3, p. 181, doi. 10.1002/cai2.43
By:
- Cheng, Ying;
- Wang, Qiming;
- Li, Kai;
- Shi, Jianhua;
- Han, Baohui;
- Wu, Lin;
- Chen, Gongyan;
- He, Jianxing;
- Wang, Jie;
- Qin, Haifeng;
- Li, Xiaoling
Publication type:
Article
Issue Information.
Published in:
Cancer Innovation, 2023, v. 2, n. 3, p. 1, doi. 10.1002/cai2.15
Publication type:
Article